Greg McKee

Greg McKee is an experienced life sciences executive, entrepreneur and investor with over 25 years of experience in the field and is currently the founder and ceo of Journey Life Sciences, a company focusing on the development of novel treatments for chronic pain through the use of unique psychoactive compounds and a member of the board of directors of Reset Pharmaceuticals.  He has previously advised Bonaventure Equity, LLC a venture fund backing the leading companies in cannabinoid and psychedelic drug development as well as the senior leadership of Numinus Wellness (TSX: NUMI) a leading company in the psychedelic and wellness fields. Previously, he served as chairman and chief executive officer of TRYP Therapeutics (ASX: TYP), a drug development company focused on commercializing a novel formulation of psilocybin for the treatment of eating disorders.

Mr. McKee was a co-founder and managing director of Torrent Ventures, a California focused digital health and medical technology firm that supports promising companies pursing break through solutions in drug development, genomics, diagnostics, medical devices, drug delivery and digital health technologies. Mr. McKee also served as chief executive officer of CONNECT, a start-up accelerator focused on creating and scaling great innovative companies across the life science and technology disciplines. DTX Pharma, a CONNECT program graduate, was recently sold to Novartis for $1B.

Prior to CONNECT he was chairman, president and chief executive officer of publicly traded Nventa Biopharmaceuticals (TSX: NVN) which merged with Akela Pharma (TSX: AKL). Additionally, he held senior management roles at Valentis, Inc.,(NASD: VLTS) and Genzyme Corporation, (NASD: GENZ)which was acquired by Sanofi for $22 billion. Mr. McKee has lived and worked in Tokyo, Japan, for seven years in investment management (Mizuho Group) during which time he managed $550M in the Japanese equity market, and investment banking (UBS).  He also held an appointment as senior advisor to the Former Minister of Foreign Affairs of Japan and speaks fluent Japanese.  Mr. McKee has also lived and worked in Singapore for 2 years managing Genzyme’s business units in South East Asia and mainland China.

Mr. McKee earned a B.A. in Economics from the University of Washington, a M.A. in International Studies from The Joseph H. Lauder Institute and an M.B.A from the Wharton School, at the University of Pennsylvania. He has been a member of Young President’s Organization (YPO) since 2006, Chapter Chair YPO Coastal San Diego, and is currently on the Board of the YPO Healthcare Business Network and Investing Network.  He is a classically trained violist and pianist and is an avid ocean swimmer, alpine skier and mountaineer.

.